DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF RISPERIDONE BY MBTH
HTML Full TextDEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF RISPERIDONE BY MBTH
S. Archana*, Y. Naga Prasanna, P. Pavitra, D. Santhi Krupa, M. Hema Sri
Research Lab., Aditya Institute of Pharmaceutical Sciences & Research, ADB Road, surampalem, Kakinada, Andhra Pradesh, India
ABSTRACT: A simple and sensitive visible spectrophotometric method is described for the assay of risperidone (RSP) in pure and solid dosage forms. The method involves oxidative coupling of risperidone with MBTH in presence of ferric chloride dissolved in HCl and apple green chromogen is formed and exhibits absorption maxima at 595.8nm. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges (10-80) μg/mL. Regression coefficient was found to be 0.992. The proposed method is applied to commercial available tablets and the results are statistically evaluated and validated by recovery studies. The proposed methods have been successfully applied to the analysis of the bulk drug and its tablet dosage form. The methods have been statistically evaluated and were found to be precise and accurate.
Keywords: |
Risperidone, 3-methyl-2-benzothiazolinone hydrazone, ferric chloride, validation
INTRODUCTION: Risperidone 1 is an antipsychotic drug which is mainly used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states associated with bipolar disorder, and irritability in people with autism. Risperidone belongs to the class of atypical antipsychotics 2. It is a dopamine antagonist possessing antiserotonergic, antiadrenergic and antihistaminergic properties. Many analytical methods like spectrophotophotometry 2-4 HPLC 5-10 , LC –MS 11, 12 , HPTLC 13,polarography 14 and have been reported for the determination of Risperidone.
EXPERIMENTAL:
Instrument: Elico double beam UV/Visible spectrophotometer (SL-210) with 1cm matched quartz cells, electronic Dona balance were used for all spectral measurements.
Reagents and Standards: All the reagents used were of analytical grade and the solutions were freshly prepared. The reagents used in this method are triple distilled water, methanol, 0.1N HCl, MBTH (0.3%) and FeCl3 (1%) .
Stock Solution: The solution 1mg/ml (1000mcg/ml) was prepared by dissolving accurately about 0.1 g of drug in 100ml of distilled water.
Preparation of MBTH Reagent: 0.3gm of MBTH reagent was dissolved in 100ml distilled water and made up to the volume to 100ml.
Preparation of Ferric Chloride Solution: 1gm of FeCl3 was dissolved in 0.1N HCl and made up to the 100ml with 0.1N HCl.
PROCEDURE: Into a series of 10ml volumetric flask , 1ml of MBTH (0.3%) and 0.8ml FeCl3 (1%) and 0.1 – 0.8ml of working standard solution (1mg/ml) were added separately. The absorbance of apple green chromogen was measured at 595.8nm against reagent blank. The amount of risperidone present in the sample solution was computed from its calibration curve. The spectrum was shown in figure 1.
FIGURE 1: SPECTRUM OF RISPERIDONE
Preparation of Sample Solution: 20 tablets of commercial samples of risperidone were accurately weighed and powdered. The tablet powder equivalent to 50 mg of risperidone was dissolved in 5 ml of methanol and made up to volume with distilled water. The solution was filtered and analyzed as given under the assay procedure for bulk samples. None of the excipients usually employed in the formulation of tablets interfered in the analysis of risperidone by the proposed method. The standard graph was plotted by taking conc. of drug on x – axis and absorbance on y– axis and was shown in figure 2. Results of regression analysis was given in table 9.
Procedure for assay of drugs in Dosage Forms: Ten tablets of commercial samples of Risperidone were accurately weighed and powdered. An amount of powder equivalent to 50mg was weighed separately and made upto 50ml with distilled water. The solution was filtered and subjected to recommended procedure for the determination. The results were displayed in table 8.
Validation Parameters:
- Linearity: The calibration curve was constructed in each case by considering the absorbance measured at eight concentration levels of Risperidone methanol ( 10-80 µg/ml) using the method of least squares, a line of best fit was taken and the correlation coefficient, slope and y-intercept was calculated. The amount of drug was computed either from calibration curve or from regression equation, the results are given in table 1.
- Accuracy: The accuracy of the method was determined by taking aliquots containing known quantity of risperidone & analyzed by proposed method & results are compared with results of reference method & tabulated in the table 2.
- Precision: The precision of the method was studied by measuring 6 replications of sample containing 20µg/ml of risperidone. The % RSD & SD was calculated and presented in table 3.
- Ruggedness: It is a measure of reproducibility of test results under normal expected operational condition from instrument to instrument & from analyst to analyst were reported in table 4 & 5.
- Specificity: Absorbance of blank solution was measured and is found to be very negligible 0.0012 hence no interference with blank solution was observed. This indicates that the method for the drug is specific.
- Robustness: The robustness of the method was followed by optimizing conditions with slight variation i.e. by altering detection wavelength (1nm) the results were reported in table 6 & 7.
RESULTS AND DISCUSSION: The presence of amino group in RSP enabled oxidative coupling with MBTH and FeCl3 to form green colored chromogen in this method exhibiting λmax at 595.8 nm. The Beer’s law was obeyed for this method in the concentration ranges of 10-80 µg/ml respectively. The optical characteristics such as Beer’s law limits (µg/ml), Molar extinction coefficient (L/mol.cm), Regression equation (y), Correlation coefficient was calculated and reported in Table 9.
To evaluate the validity and reproducibility of the method, known amount of pure drug was added to the previously analyzed pharmaceutical preparation and the mixtures were analyzed by the proposed method. The percent recoveries are given in Table 2.
FIGURE 2: LINEARITY PLOT
TABLE 1: LINEARITY
S.NO | CONCENTRATION
(µg/ml) |
ABSORBANCE |
1 | 10 | 0.155 |
2 | 20 | 0.255 |
3 | 30 | 0.351 |
4 | 40 | 0.452 |
5 | 50 | 0.556 |
6 | 60 | 0.648 |
7 | 70 | 0.731 |
8 | 80 | 0.815 |
TABLE 2: ACCURACY
Spike level | Amount present | Amount received | %recovered |
80% | 40mcg/ml | 39.96 | 99.9% |
100% | 50mcg/ml | 49.99 | 99.98% |
120% | 60mcg/ml | 60.18 | 100% |
TABLE 3: PRECISION
Concentration(µg/ml) | 6 replicates |
50 | 0.556 |
50 | 0.549 |
50 | 0.551 |
50 | 0.549 |
50 | 0.555 |
50 | 0.556 |
Average | 0.5526 |
Std.deviation | 0.003386 |
%RSD | 0.6127 |
Ruggedness
TABLE 4: INSTRUMENT VARIATION
Concentration (µg/ml) | Instrumental-1 | Instrumental-2 |
50 | 0.556 | 0.551 |
50 | 0.554 | 0.556 |
50 | 0.55 | 0.549 |
50 | 0.561 | 0.566 |
50 | 0.564 | 0.548 |
Average | 0.555667 | 0.555167 |
Std.deviation | 0.005955 | 0.007195 |
%RSD | 1.071756 | 1.29599 |
TABLE 5: ANALYST VARIATION
Concentration (µg/ml) | Analyst-1 | Analyst-2 |
50 | 0.556 | 0.548 |
50 | 0.554 | 0.543 |
50 | 0.55 | 0.537 |
50 | 0.549 | 0.546 |
50 | 0.561 | 0.538 |
50 | 0.564 | 0.552 |
Average | 0.555667 | 0.544 |
Std.deviation | 0.005955 | 0.005831 |
%RSD | 1.071756 | 1.071866 |
Robustness
- TABLE 6: 50mcg/ml :
Wavelength (nm) | |||
594.8 | 0.561 | 0.556 | 0.553 |
595.8 | 0.548 | 0.551 | 0.553 |
596.8 | 0.545 | 0.549 | 0.545 |
Average | 0.551 | 0.552 | 0.550 |
Standard deviation | 0.008505 | 0.003606 | 0.004619 |
%RSD | 1.54 | 0.653 | 0.839 |
- TABLE 7: 60mcg/ml
Wavelength(nm) | |||
594.8 | 595.8 | 596.8 | 0.651 |
595.8 | 595.8 | 596.8 | 0.655 |
596.8 | 0.654 | 0.653 | 0.657 |
Average | 0.650 | 0.650 | 0.654 |
Standard deviation | 0.004583 | 0.002517 | 0.003055 |
%RSD | 0.7050 | 0.387 | 0.467 |
TABLE 8: ASSAY OF RISPERIDONE TABLETS.
Sample (tablet) | Labeled amount mg | Amount obtained mg* | **%Recovery by the proposed method |
1 | 50 | 49.98
49.88 |
99.96
99.76 |
2 | 50 |
*Average of three determinations; ** After spiking the sample
CONCLUSION: The developed method is simple, rapid, selective and inexpensive and exhibits a fair degree of precision and accuracy. The present methods involve the formation of highly stable colored species which makes it easier for the determination of risperidone from pharmaceutical dosage forms in a routine manner. The method does not involve any critical reaction conditions. The proposed method can serve as an alternative method for the routine analysis of RSP in pure drug and in pharmaceutical formulations.
ACKNOWLEDGEMENTS: The authors are thankful to Orchid healthcare for gift sample of drug for research. The authors are also thankful to the Principal, Aditya institute of pharmaceutical sciences and research for providing laboratory facilities.
REFERENCES
- www.wikipedia.com
- Sravan Kumar M,Anton Smith A, Alagumani Vasagam G., Kottai Muthu A. and Manavalan R., Spectrophotometric determination of risperidone using HCL as a solvent in bulk and pharmaceutical dosage form, International Journal of Pharma Sciences and Research (IJPSR),Vol.1(2), 2010,122-126.
- Rahman Z, Hassan Well-S, Extractive colorimetric methods for analysis of Sdothiepinhydrochloride (I) and risperidone (II) in bulk sample and in dosage forms, Chem Pharm Bull (Tokyo). 2008 Aug; 56(8):1092-6.
- Narayana and Divya N. Shetty, Spectrophotometric determination of risperidone by oxidation of the drug using chloramine-T, Der Pharmacia Lettre, 2011: 3 (5), 104-109,
- Baladania S.L., Bhatt KK., Mehtha RS., shah DA., RP-HPLC estimation of risperidone in tablet dosage form, Indian journal of pharmaceutical sciences, Year: 2008, Volume: 70, Issue: 4, 494-497.
- Ming-zhu Huang, Jian-zhong Shentu, Jun-chun Chen, Jian Liu, and Hui-li Zhou, Determination of risperidone in human plasma by HPLC-MS/MS. Journal of Zhejiang University Science, 2008 February; 9(2): 114–120.
- Ole Vendelin Olesen, Kristian Linney, Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum, Journal of Chromatography B: Biomedical Sciences and Applications, Volume 698, Issues 1–2, 26 September 1997, 209–216.
- Zarna R. Dedania, Ronak R. Dedania, Navin R. Sheth, Jigar B. Patel, and Bhavna Patel, Stability Indicating HPLC Determination of Risperidone in Bulk Drug and Pharmaceutical Formulations, International Journal of Analytical Chemistry, Volume 2011 (2011), Article ID 124917, pages 6.
- P. Suthar1, S. A. Dubey, S. R. Patel, A. M. Shah1, Determination of Risperidone and forced degradation behavior by HPLC in tablet dosage form, International Journal of PharmTech Research, Vol.1, No.3, July-Sept 2009, pages 568-574
- Manickam Aravagiri;Stephen R.Theodore van Putten, Kamal K. Midha, Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection, Journal of Pharmaceutical Sciences, Volume 82, Issue 5, Article first published online: 28 SEP 2006.
- Schneider S, Sibille E, Yegles M, Neels H, Wennig R, Mühe A, Time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using LC/MS-MS, J Chromatogr B Analyst Technol Biomed Life Sci. 2009 Aug 15;877(24): pages 89-92.
- Bhatt J, Subbaiah G, Singh S, Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma, US national library of medicine national institute of health, 2006; 20(14); 09-14.
- Patel R. B., Patel B. G., Patel M. R., Bhatt K. K. , HPTLC method development and validation for analysis of risperidone in formulations, Actachromatographica journal of chemistry, Volume 22, number 4, December 2010.
- Christine Jeyaseelan,A Ravin Jugade,b,* and Arun P. Joshia, Differential Pulse Polarographic Studies of Risperidone in Pharmaceutical Formulations, Original scientific paper.croatica chemical actaccacaa 79(4); 541-544(2006).
How to cite this article:
Archana S, Prasanna YN, Pavitra P, Krupa DS, Sri MH: Development and Validation of Spectrophotometric method for determination of Risperidone by MBTH. Int J Pharm Sci Res 2013; 4(3); 1116-1119.
Article Information
31
1116-1119
483KB
1446
English
IJPSR
S. Archana*, Y. Naga Prasanna, P. Pavitra, D. Santhi Krupa, M. Hema Sri
Research Lab., Aditya Institute of Pharmaceutical Sciences & Research, ADB Road, surampalem, Kakinada, Andhra Pradesh, India
avanthiarchana@gmail.com
27 November, 2012
22 January, 2013
23 February, 2013
http://dx.doi.org/10.13040/IJPSR.0975-8232.4(3).1116-19
01 March, 2013